AT347476B - Verfahren zur herstellung neuer thiocarbamid- derivate - Google Patents
Verfahren zur herstellung neuer thiocarbamid- derivateInfo
- Publication number
- AT347476B AT347476B AT185776A AT185776A AT347476B AT 347476 B AT347476 B AT 347476B AT 185776 A AT185776 A AT 185776A AT 185776 A AT185776 A AT 185776A AT 347476 B AT347476 B AT 347476B
- Authority
- AT
- Austria
- Prior art keywords
- producing new
- thiocarbamide derivatives
- thiocarbamide
- derivatives
- producing
- Prior art date
Links
- 229940042794 thiocarbamide derivative for treatment of tuberculosis Drugs 0.000 title 1
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical class NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/04—Derivatives of thiourea
- C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
- C07C335/10—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C335/12—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU75GO1303A HU173459B (hu) | 1975-03-14 | 1975-03-14 | Sposob poluchenija novykh proizvodnykh tiomocheviny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA185776A ATA185776A (de) | 1978-05-15 |
| AT347476B true AT347476B (de) | 1978-12-27 |
Family
ID=10996785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT185776A AT347476B (de) | 1975-03-14 | 1976-03-12 | Verfahren zur herstellung neuer thiocarbamid- derivate |
Country Status (18)
| Country | Link |
|---|---|
| AT (1) | AT347476B (sv) |
| BE (1) | BE839502A (sv) |
| CA (1) | CA1069931A (sv) |
| CH (1) | CH619210A5 (sv) |
| CS (1) | CS188132B2 (sv) |
| DD (1) | DD125615A5 (sv) |
| DE (1) | DE2610865A1 (sv) |
| DK (1) | DK107876A (sv) |
| EG (1) | EG12505A (sv) |
| FR (1) | FR2303532A1 (sv) |
| GB (1) | GB1499485A (sv) |
| HU (1) | HU173459B (sv) |
| IL (1) | IL49194A (sv) |
| IN (1) | IN143559B (sv) |
| NL (1) | NL7602670A (sv) |
| PL (1) | PL101310B1 (sv) |
| SE (1) | SE7603242L (sv) |
| SU (1) | SU795462A3 (sv) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU206082B (en) * | 1988-12-23 | 1992-08-28 | Sandoz Ag | Process for producing capsaicin derivatives and pharmaceutical compositions comprising such compounds |
| US7335803B2 (en) | 2001-10-19 | 2008-02-26 | Allergan, Inc. | Methods and compositions for modulating alpha adrenergic receptor activity |
| US6545182B2 (en) * | 2000-04-13 | 2003-04-08 | Allergan Sales, Inc. | Methods and compositions for modulating alpha adrenergic receptor activity |
| US6313172B1 (en) | 2000-04-13 | 2001-11-06 | Allergan Sales, Inc. | Methods and compositions for modulating alpha adrenergic receptor activity |
| US6534542B2 (en) | 2001-02-27 | 2003-03-18 | Allergen Sales, Inc. | (2-hydroxy)ethyl-thioureas useful as modulators of α2B adrenergic receptors |
| US7323485B2 (en) | 2002-05-21 | 2008-01-29 | Allergan, Inc. | 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| US7358269B2 (en) | 2002-05-21 | 2008-04-15 | Allergan, Inc. | 2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-one |
| US7276522B2 (en) | 2002-05-21 | 2007-10-02 | Allergan, Inc. | 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| US7091232B2 (en) | 2002-05-21 | 2006-08-15 | Allergan, Inc. | 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| NZ553290A (en) | 2004-09-24 | 2010-11-26 | Allergan Inc | 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| JP2008514603A (ja) | 2004-09-24 | 2008-05-08 | アラーガン、インコーポレイテッド | α２アドレナリン作動剤としての４−（ヘテロアリール−メチルおよび置換ヘテロアリール−メチル）−イミダゾール−２−チオン |
| JP2008514601A (ja) | 2004-09-24 | 2008-05-08 | アラーガン、インコーポレイテッド | 特異的α２アドレナリン作動剤としての４−（フェニルメチルおよび置換フェニルメチル）−イミダゾール−２−チオン |
| CA2582071A1 (en) | 2004-09-28 | 2006-04-06 | Allergan, Inc. | Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| US7390829B2 (en) | 2005-06-29 | 2008-06-24 | Allergan, Inc. | Alpha-2 adrenergic agonists |
| US7902247B2 (en) | 2008-01-09 | 2011-03-08 | Allergan, Inc. | Substituted-aryl-2-phenylethyl-1H-imidazole compounds as subtype selective modulators of alpha 2B and/or alpha 2C adrenergic receptors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB974545A (en) * | 1963-03-14 | 1964-11-04 | Baxter Laboratories Inc | Thioureas |
-
1975
- 1975-03-12 SU SU752333906A patent/SU795462A3/ru active
- 1975-03-14 HU HU75GO1303A patent/HU173459B/hu unknown
-
1976
- 1976-03-10 IL IL49194A patent/IL49194A/xx unknown
- 1976-03-11 CS CS761604A patent/CS188132B2/cs unknown
- 1976-03-12 SE SE7603242A patent/SE7603242L/sv not_active Application Discontinuation
- 1976-03-12 DK DK107876A patent/DK107876A/da not_active Application Discontinuation
- 1976-03-12 AT AT185776A patent/AT347476B/de not_active IP Right Cessation
- 1976-03-12 FR FR7607110A patent/FR2303532A1/fr active Granted
- 1976-03-12 CA CA247,778A patent/CA1069931A/en not_active Expired
- 1976-03-12 DD DD191816A patent/DD125615A5/xx unknown
- 1976-03-12 BE BE165107A patent/BE839502A/xx unknown
- 1976-03-12 CH CH307076A patent/CH619210A5/de not_active IP Right Cessation
- 1976-03-13 PL PL1976187917A patent/PL101310B1/pl unknown
- 1976-03-14 EG EG152/76A patent/EG12505A/xx active
- 1976-03-15 IN IN456/CAL/1976A patent/IN143559B/en unknown
- 1976-03-15 GB GB10200/76A patent/GB1499485A/en not_active Expired
- 1976-03-15 NL NL7602670A patent/NL7602670A/xx not_active Application Discontinuation
- 1976-03-15 DE DE19762610865 patent/DE2610865A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| IL49194A0 (en) | 1976-05-31 |
| CS188132B2 (en) | 1979-02-28 |
| IN143559B (sv) | 1977-12-24 |
| ATA185776A (de) | 1978-05-15 |
| DE2610865A1 (de) | 1976-09-30 |
| SU795462A3 (ru) | 1981-01-07 |
| CA1069931A (en) | 1980-01-15 |
| FR2303532B1 (sv) | 1978-12-15 |
| EG12505A (en) | 1980-07-31 |
| IL49194A (en) | 1980-09-16 |
| DD125615A5 (sv) | 1977-05-04 |
| HU173459B (hu) | 1979-05-28 |
| PL101310B1 (pl) | 1978-12-30 |
| CH619210A5 (en) | 1980-09-15 |
| DK107876A (da) | 1976-09-15 |
| FR2303532A1 (fr) | 1976-10-08 |
| NL7602670A (nl) | 1976-09-16 |
| GB1499485A (en) | 1978-02-01 |
| SE7603242L (sv) | 1976-10-15 |
| BE839502A (fr) | 1976-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT359217B (de) | Verfahren zur herstellung neuer peptid-derivate | |
| AT342770B (de) | Verfahren zur herstellung neuer erythromycinderivate | |
| AT347476B (de) | Verfahren zur herstellung neuer thiocarbamid- derivate | |
| ATA343276A (de) | Verfahren zur herstellung neuer rifamycin-verbindungen | |
| AT340888B (de) | Verfahren zur herstellung neuer quartarer ammoniumverbindungen | |
| DD133949A5 (de) | Verfahren zur herstellung neuer benzopyranderivate | |
| AT352918B (de) | Verfahren zur herstellung neuer histidin- derivate | |
| ATA343076A (de) | Verfahren zur herstellung neuer rifamycin-verbindungen | |
| ATA986075A (de) | Verfahren zur herstellung neuer indolderivate | |
| AT357155B (de) | Verfahren zur herstellung neuer imidazol- derivate | |
| DD128130A5 (de) | Verfahren zur herstellung neuer pyrazol-derivate | |
| ATA924875A (de) | Verfahren zur herstellung neuer 5-nitroimida- zolderivate | |
| ATA736576A (de) | Verfahren zur herstellung neuer indolderivate | |
| AT351046B (de) | Verfahren zur herstellung neuer diharnstoffe | |
| DD131558A5 (de) | Verfahren zur herstellung neuer indolizinderivate | |
| AT348976B (de) | Verfahren zur herstellung neuer sekundaerer aetheraminacetate | |
| AT343136B (de) | Verfahren zur herstellung neuer phosphinyl-derivate | |
| AT344898B (de) | Verfahren zur herstellung neuer rifamycin-verbindungen | |
| ATA759579A (de) | Verfahren zur herstellung neuer ergolinderivate | |
| ATA759479A (de) | Verfahren zur herstellung neuer ergolinderivate | |
| ATA302477A (de) | Verfahren zur herstellung neuer phosphinyl-derivate | |
| ATA302377A (de) | Verfahren zur herstellung neuer phosphinyl-derivate | |
| AT349009B (de) | Verfahren zur herstellung neuer indazol-3- carbonsaeurehydrazid-derivate | |
| ATA281677A (de) | Verfahren zur herstellung neuer erythromycinderivate | |
| AT341531B (de) | Verfahren zur herstellung neuer octahydropyridoindolobenzazepine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |